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Giant coronary artery aneurysm is rare. A 71-year-old female was referred to 
our hospital 3 months after onset of symptoms. Work-up including coronary 
angiogram and computed tomographic angiogram helped a definite diagnosis of 
a giant aneurysm of the circumflex coronary artery. The patient was conservatively 
managed with a close follow-up. In this article, this rare lesion was presented with 
associated anomalies. (Folia Morphol 2014; 73, 3: 370–373)
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INTRODUCTION
Coronary artery aneurysm (CAA) is uncommon, 
and giant CAA is even rarer with an estimated inciden-
ce ranging between 0.02% and 0.04% [10, 15]. Giant 
CAA was defined as a CAA with a diameter > 4 times 
of the reference artery, or with a diameter > 8 mm [9]. 
CAA is most common in the right coronary artery 
(RCA), more common in the left anterior descending 
coronary artery (LAD) or circumflex coronary artery 
(Cx), and least common in the left main trunk [4]. The 
frequencies of the giant CAAs in individual coronary 
arteries showed a similar sequencing to that of the 
CAAs in general, being the most common in the RCA, 
more common in the LAD, and least common in the 
left main trunk and diagonal branch [8].
Both solitary and multiple CAAs involving the Cx 
were described in the literature. Assiri [1] reported 
a solitary one extending 6.6 cm in diameter being the 
largest one of the time, which was not scheduled for 
a surgical intervention. Multiple CAAs involving the Cx 
have been previously described [15]. Giant aneurysm 
of the Cx is even much rarer. It may be associated 
with a fistula communicating to cardiac chambers 
[20], or to the coronary sinus [6]. However, a giant 
CAA is rarely associated with coronary tortuosity. 
This report describes a unique case of CAA of the 
Cx associated with tortuosity and coiling of the coro-
nary arteries, aortic valve regurgitation, and tortuosity 
of the radial artery.
CASE REPORT
A 71-year-old female was referred to this hospital due 
to facial and pedal oedema and exertional chest distress 
for 3 months. She also complained of paraesthesia of her 
right leg, and Parkison’s symptoms like gait disorders and 
tremor, etc. She had been diagnosed with coronary artery 
disease (CAD), and thus took daily trimetazidine consecu-
tively for many years. Echocardiography in a local district 
hospital suggested a congenital aorta-pulmonary fistula 
7 months prior to admission. On admission, her vital signs 
were normal. An intermittent grade I–II/VI systolic drum-
-like murmur could be audible by cardiac auscultation in 
a few heartbeats when the patient was in a supine posi-
tion. Elevation of the left main bronchus and left atrial oe-
sophagus impression were seen on chest roentgenogram 
by a barium swallow. Electrocardiogram showed sinus 
rhythm with occasional premature atrial contractions 
with a heart rate of 76 bpm. Echocardiography revealed 
moderate aortic valve regurgitation, and enlarged left 
atrium (39 mm), and dilated ascending aorta (40 mm) and 
pulmonary trunk (32 mm). Cardiac angiograms were per-
formed via right radial artery. The catheter insertion was 
eventually successful after careful repeated trails through 
3 tortuous segments of the radial artery (Figs. 1A, B). 
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Coronary angiograms revealed a convoluted LAD, 
a giant CAA arising from the Cx (Fig. 1C), and a smooth 
RCA but with an upwardly convoluted branch (Fig. 1D) 
without significant stenosis. Aortogram demonstra-
ted moderate aortic valve regurgitation in addition 
to the findings of the coronary angiograms (Fig. 1E). 
Chest computed tomography showed dilations of the 
ascending aorta and pulmonary artery, and a giant 
aneurysm adjacent to the ascending aorta, left atrium 
and left ventricle (Figs. 2A, B). Computed tomograp-
hic angiogram illustrated a giant CAA of the Cx with 
intramural thrombus formation and calcified aneu-
rysmal walls (Figs. 2C, D). The coronary arteries were 
diffusely dilated with focal calcifications (Figs. 2E, F). 
Tortuosity of the left anterior descending coronary ar-
tery and colling of the upward right coronary artery 
branch could be seen on three-dimensional (3D) re-
construction of computed tomography (Figs. 2G, H). 
She was diagnosed with a giant CAA of the Cx, diffuse 
dilation and tortuosity of the coronary arteries, dilations 
of the ascending aorta and pulmonary artery, aortic 
valve regurgitation, and tortuosity of the radial artery. 
The patient’s family preferred a conservative treatment. 
The patient was treated with intense anticoagulant, cal-
cium-antagonist, and beta-blockage, and withdrawal of 
trimetazidine. Her symptoms were relieved, and she was 
discharged home. She was doing well free of symptoms at 
a 2-month follow-up.
Figure 1. Cardiac angiograms performed via right 
radial artery; A, B. Tortuosity of the right radial 
artery with one lesion in the proximal and two 
lesions in the distal portion of the artery (arrows); 
C. Coronary angiograms showing tortuosity of the 
left anterior descending coronary artery (LAD), 
and a giant aneurysm of the circumflex coronary 
artery (Cx); D. A smooth right coronary artery 
with an upward convoluted branch (arrow); and 
E. An aortogram demonstrated moderate aortic valve 
regurgitation (arrows) in addition to the findings 
of the coronary angiograms; CAA — coronary 
artery aneurysm; LM — left main trunk.
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Figure 2. Computed tomography of the giant 
coronary artery aneurysm; A. A postero-anterior 
view showing a giant aneurysm adjacent to the 
ascending aorta, left atrium and left ventricle (ar-
row); B. An axial view showing enlarged ascen-
ding aorta (47.53 mm) and a giant coronary artery 
aneurysm (67.54 mm) with calcified aneurysmal 
walls and large intramural thrombus (arrow); C–F. 
Computed tomographic angiogram showing diffu-
sely dilated coronary arteries with focal calcifica-
tions: C. Left anterior descending coronary artery 
9.07 mm; D. Circumflex coronary artery 8.91 mm; 
E. First diagonal branch 4.02 mm; F. Mid right 
coronary artery 4.35 mm and distal right coronary 
artery 2.20 mm; and G–H. Three-dimensional (3D) 
reconstruction of computed tomography showing 
tortuosity of the left anterior descending coronary 
artery and coiling of the upward right coronary 
artery branch.
DISCUSSION
CAAs are of atherosclerotic, systemic inflam-
matory (Kawasaki disease, Behcet’s disease, and 
Takayasu’s aortitis, etc.), or congenital etiologies 
[7]. Patients typically manifest symptoms similar 
to those of CAD, and therefore it is often misdiag-
nosed as angina pectoris [5]. The management of 
CAA includes medical, surgical, and interventional 
treatments. Medical treatment with antiplatelet 
and anticoagulant agents is effective in preventing 
from progress of the CAA and potential compli-
cations [8]. Surgical management is reserved for 
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symptomatic patients, patients with progressing 
CAAs, or those with complications, such as CAD 
[19]. Aggressive surgical excision or plication is 
indicated for the CAAs that progress and are pen-
ding to rupture [17]. Ligation, excision, plication, 
and aneurysmorrhaphy, and cardiac transplantation 
in extreme occasions, have been performed with 
success [17]. Stent deployments causing coronary 
aneurysm months or years after the procedure have 
been reported [8]. In spite of satisfactory results of 
early postoperative period, long-term outcomes of 
bypass grafts in patients with giant CAAs secon-
dary to Kawasaki disease remain to be evaluated 
[2]. Patients with Behçet’s disease with coronary 
artery involvements carried higher postoperative 
morbidity and reintervention rates after cardiotho-
racic interventions [21]. Therefore, CAA patients 
are likely to be restrained in terms of aggressive 
surgical or interventional therapies.
Arterial tortuosity is not an uncommon vascular 
morphological abnormality. The prevalence of coronary 
tortuosity was 39.1% with significant female prepon-
derance [12]. Tortuosity of the artery was categorised 
into 3 types: 1) tortuosity: the artery straggles into 
“C”, “U”, or “S” forms; 2) coiling: the artery convolutes 
into 1 or more arterial loops on its axis; and 3) kinking: 
the artery convolutes and forms into an acute angle. 
Arterial kinking often leads to the onset of symptoms, 
whereas arterial coiling does not [11]. Coronary tor-
tuosity is benign, but may be associated with angina 
pectoris, cardiac arrhythmias, and myocardial stunning 
[13]. The detection rate of coronary tortuosity was 
not high, and this disorder implicates confounding 
with CAD due to similar symptoms to angina. Luo et 
al. [14] observed that intravenous cinepazide malea-
te injection 320 mg per day for consecutive 14 days 
resulted in considerable improvements of symptoms 
and electrocardiogram alterations.
Trimetazidine is a safe, effective agent for the 
treatment of angina pectoris. It has been proved to 
be as good as propranolol (120–160 mg/day) and 
nifedipine (40 mg/day) in relieving anginal episo-
des and improving exercise tolerance [3]. However, 
trimetazidine may induce parkinsonism, or exagge-
rate previously diagnosed Parkinson’s disease [16]. 
Parkison’s symptoms may be resolved or improved 
after trimetazidine withdrawal [18].
CONCLUSIONS
In conclusion, a giant CAA of the Cx is rare. In 
patients with mild symptoms without critical com-
plications or an associated fistula, and in those with 
diffuse dilation of the coronary arteries, a conservative 
treatment may be preferable for the prevention of 
potential postoperative complications.
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